- Latest available (Revised)
- Original (As made)
There are currently no known outstanding effects for the The Medical Devices (Northern Ireland Protocol) Regulations 2021, PART 2.
Revised legislation carried on this site may not be fully up to date. At the current time any known changes or effects made by subsequent legislation have been applied to the text of the legislation you are viewing by the editorial team. Please see ‘Frequently Asked Questions’ for details regarding the timescales for which new effects are identified and recorded on this site.
5. The reprocessing and further use of single-use devices is permitted only when it is carried out in accordance with Article 17.
Commencement Information
I1Reg. 5 in force at 27.7.2021, see reg. 1(2)
6. A health institution which has implanted a device to which Article 18 applies, must make available to the patient in whom the device has been implanted—
(a)the implant card for the device bearing the health institution’s identity, and
(b)the information provided by the manufacturer with the device pursuant to Article 18(1), by any means that allow rapid access to that information.
Commencement Information
I2Reg. 6 in force at 27.7.2021, see reg. 1(2)
7.—(1) A manufacturer who makes custom-made devices available on the market in Northern Ireland must register that type of device with the Secretary of State.
(2) Registration—
(a)must take place within 28 days beginning with the day on which that type of device is first made available on the market, and
(b)requires the manufacturer to submit to the Secretary of State the information specified in paragraph (3).
(3) The information to be submitted to the Secretary of State is—
(a)the name, business address and contact details of the manufacturer of the device;
(b)if an authorised representative has been designated by the manufacturer, the authorised representative’s name, business address, contact details and evidence of that designation;
(c)a description of the type of device concerned.
(4) The manufacturer must ensure that the information submitted to the Secretary of State remains up to date.
(5) The fee payable to the Secretary of State for registering a device or amending the registration of a device under this regulation is [F1£240].
(6) This regulation does not apply before 1st September 2021 in respect of any class IIa or class IIb non-implantable devices made available on the market by a manufacturer who is not established in the United Kingdom.
Textual Amendments
F1Sum in reg. 7(5) substituted (1.4.2023) by The Medical Devices and Blood Safety and Quality (Fees Amendment) Regulations 2023 (S.I. 2023/377), regs. 1(2), 19
Commencement Information
I3Reg. 7 in force at 27.7.2021, see reg. 1(2)
8. A manufacturer or authorised representative who requests a certificate of free sale from the Secretary of State under Article 60(1), must pay to the Secretary of State a fee of £75.
Textual Amendments
F2Words in reg. 8 heading inserted (21.3.2024) by The Medical Devices (In Vitro Diagnostic Devices etc.) (Amendment) Regulations 2024 (S.I. 2024/221), regs. 1(2), 31
Commencement Information
I4Reg. 8 in force at 27.7.2021, see reg. 1(2)
9.—(1) The liquidator or trustee in bankruptcy of a manufacturer, or of an authorised representative, must—
(a)retain for the required period any documentation that consists of, or reasonably could consist of, information to which section 8 of Annex IX applies, and
(b)comply with any request made by the Secretary of State during the required period to provide the Secretary of State with the retained documentation.
(2) In this regulation, the required period is—
(a)in the case of information relating to an implantable device, 15 years after the last device was placed on the market, and
(b)in any other case, 10 years after the last device was placed on the market.
Commencement Information
I5Reg. 9 in force at 27.7.2021, see reg. 1(2)
10.—(1) This regulation applies if the CE marking is affixed in accordance with Article 20 on the basis of a certificate issued by a notified body established in the United Kingdom.
(2) The CE marking must be accompanied by the UK(NI) indication.
(3) The UK(NI) indication may be less than 5mm high provided that it is the same height as the CE marking that it accompanies.
(4) The manufacturer must affix the UK(NI) indication—
(a)visibly, legibly and indelibly, and
(b)before placing the device on the market F4....
(5) A person may only make available on the market F5... a device to which this regulation applies if the manufacturer has affixed the UK(NI) indication in accordance with this regulation.
F6(6) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Textual Amendments
F3Words in reg. 10 heading inserted (21.3.2024) by The Medical Devices (In Vitro Diagnostic Devices etc.) (Amendment) Regulations 2024 (S.I. 2024/221), regs. 1(2), 32(a)
F4Words in reg. 10(4)(b) omitted (21.3.2024) by virtue of The Medical Devices (In Vitro Diagnostic Devices etc.) (Amendment) Regulations 2024 (S.I. 2024/221), regs. 1(2), 32(b)
F5Words in reg. 10(5) omitted (21.3.2024) by virtue of The Medical Devices (In Vitro Diagnostic Devices etc.) (Amendment) Regulations 2024 (S.I. 2024/221), regs. 1(2), 32(c)
F6Reg. 10(6) omitted (21.3.2024) by virtue of The Medical Devices (In Vitro Diagnostic Devices etc.) (Amendment) Regulations 2024 (S.I. 2024/221), regs. 1(2), 32(d)
Commencement Information
I6Reg. 10 in force at 27.7.2021, see reg. 1(2)
Latest Available (revised):The latest available updated version of the legislation incorporating changes made by subsequent legislation and applied by our editorial team. Changes we have not yet applied to the text, can be found in the ‘Changes to Legislation’ area.
Original (As Enacted or Made): The original version of the legislation as it stood when it was enacted or made. No changes have been applied to the text.
Geographical Extent: Indicates the geographical area that this provision applies to. For further information see ‘Frequently Asked Questions’.
Show Timeline of Changes: See how this legislation has or could change over time. Turning this feature on will show extra navigation options to go to these specific points in time. Return to the latest available version by using the controls above in the What Version box.
Explanatory Memorandum sets out a brief statement of the purpose of a Statutory Instrument and provides information about its policy objective and policy implications. They aim to make the Statutory Instrument accessible to readers who are not legally qualified and accompany any Statutory Instrument or Draft Statutory Instrument laid before Parliament from June 2004 onwards.
Access essential accompanying documents and information for this legislation item from this tab. Dependent on the legislation item being viewed this may include:
This timeline shows the different points in time where a change occurred. The dates will coincide with the earliest date on which the change (e.g an insertion, a repeal or a substitution) that was applied came into force. The first date in the timeline will usually be the earliest date when the provision came into force. In some cases the first date is 01/02/1991 (or for Northern Ireland legislation 01/01/2006). This date is our basedate. No versions before this date are available. For further information see the Editorial Practice Guide and Glossary under Help.
Use this menu to access essential accompanying documents and information for this legislation item. Dependent on the legislation item being viewed this may include:
Click 'View More' or select 'More Resources' tab for additional information including: